Royal Bank Of Canada Forecasts Strong Price Appreciation for Albemarle (NYSE:ALB) Stock

Albemarle (NYSE:ALB) had its price objective lifted by stock analysts at Royal Bank Of Canada from $216.00 to $245.00 in a note issued to investors on Friday, Marketbeat reports. The firm presently has an “outperform” rating on the specialty chemicals company’s stock. Royal Bank Of Canada’s price target would indicate a potential upside of 30.25% from the company’s current price.

Other research analysts have also recently issued research reports about the stock. Bank of America boosted their price target on shares of Albemarle from $190.00 to $225.00 and gave the company a “buy” rating in a research report on Tuesday, April 21st. Evercore raised their price objective on shares of Albemarle from $100.00 to $180.00 in a research report on Wednesday, February 18th. Scotiabank raised shares of Albemarle from a “sector perform” rating to a “sector outperform” rating and lifted their target price for the stock from $85.00 to $200.00 in a research note on Monday, January 12th. Mizuho increased their price target on shares of Albemarle from $156.00 to $185.00 and gave the company a “neutral” rating in a research note on Thursday, February 12th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of Albemarle from $185.00 to $195.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, thirteen have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $177.48.

Albemarle Price Performance

ALB stock opened at $188.10 on Friday. Albemarle has a 1 year low of $53.70 and a 1 year high of $215.71. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.23 and a quick ratio of 1.57. The firm has a market capitalization of $22.18 billion, a PE ratio of -32.71, a price-to-earnings-growth ratio of 1.46 and a beta of 1.43. The business has a 50 day simple moving average of $176.48 and a 200-day simple moving average of $149.10.

Albemarle (NYSE:ALB) last released its quarterly earnings data on Wednesday, February 11th. The specialty chemicals company reported ($0.53) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.13). The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.34 billion. Albemarle had a positive return on equity of 0.41% and a negative net margin of 10.74%.The business’s quarterly revenue was up 15.9% on a year-over-year basis. During the same period last year, the firm posted ($1.09) EPS. Equities research analysts anticipate that Albemarle will post 8.28 earnings per share for the current fiscal year.

Insider Buying and Selling at Albemarle

In other Albemarle news, CEO J Kent Masters sold 11,783 shares of Albemarle stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of $170.81, for a total transaction of $2,012,654.23. Following the completion of the sale, the chief executive officer directly owned 134,628 shares in the company, valued at $22,995,808.68. This trade represents a 8.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.42% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Albemarle

Hedge funds have recently made changes to their positions in the stock. Strategic Advocates LLC purchased a new stake in Albemarle in the third quarter valued at approximately $25,000. MH & Associates Securities Management Corp ADV purchased a new position in shares of Albemarle during the fourth quarter worth $26,000. BOKF NA grew its stake in shares of Albemarle by 5,771.4% in the third quarter. BOKF NA now owns 411 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 404 shares in the last quarter. Cromwell Holdings LLC grew its stake in shares of Albemarle by 36.8% in the third quarter. Cromwell Holdings LLC now owns 413 shares of the specialty chemicals company’s stock valued at $34,000 after buying an additional 111 shares in the last quarter. Finally, Elyxium Wealth LLC purchased a new stake in shares of Albemarle in the 4th quarter valued at $34,000. Hedge funds and other institutional investors own 92.87% of the company’s stock.

Trending Headlines about Albemarle

Here are the key news stories impacting Albemarle this week:

• Positive Sentiment: Royal Bank of Canada raised its price target to $245 and kept an Outperform rating, reinforcing upside potential from re-rating and fundamentals. RBC price target raise to $245
• Positive Sentiment: Zacks upgraded ALB to a Rank #2 (Buy), which can attract momentum and retail flows into the stock. Zacks upgrade to Buy
• Positive Sentiment: ALB has shown strong recent momentum (about +14% over one week), which supports continued buying interest from momentum investors. ALB up 13.89% in one week
• Neutral Sentiment: Analyst coverage is broadly positive (many buy/outperform ratings and a median price target near $207), giving a constructive medium-term backdrop but mixed near-term signals. Analyst coverage and targets summary
• Neutral Sentiment: Comparative analysis vs. peers (e.g., SQM) highlights Albemarle’s exposure to recovering lithium demand and capacity ramps; useful context but not an immediate catalyst. ALB vs SQM comparison
• Negative Sentiment: Rothschild & Co Redburn downgraded Albemarle to Neutral from Buy, warning that improving spot lithium prices may not translate immediately into company margins — a key near-term headwind ahead of Q1 results. Redburn downgrade note
• Negative Sentiment: Market headlines report the stock slipping amid broader sector volatility and profit-taking; upcoming Q1 earnings (scheduled for after the close on May 6) raises the risk of positioning-driven swings. ALB sinks as market gains

About Albemarle

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.